Hypoxia Pathway Proteins are Master Regulators of Erythropoiesis

Erythropoiesis is a complex process driving the production of red blood cells. During homeostasis, adult erythropoiesis takes place in the bone marrow and is tightly controlled by erythropoietin (EPO), a central hormone mainly produced in renal EPO-producing cells. The expression of EPO is strictly...

Full description

Bibliographic Details
Main Authors: Deepika Watts, Diana Gaete, Diego Rodriguez, David Hoogewijs, Martina Rauner, Sundary Sormendi, Ben Wielockx
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/21/8131
_version_ 1797549278226284544
author Deepika Watts
Diana Gaete
Diego Rodriguez
David Hoogewijs
Martina Rauner
Sundary Sormendi
Ben Wielockx
author_facet Deepika Watts
Diana Gaete
Diego Rodriguez
David Hoogewijs
Martina Rauner
Sundary Sormendi
Ben Wielockx
author_sort Deepika Watts
collection DOAJ
description Erythropoiesis is a complex process driving the production of red blood cells. During homeostasis, adult erythropoiesis takes place in the bone marrow and is tightly controlled by erythropoietin (EPO), a central hormone mainly produced in renal EPO-producing cells. The expression of EPO is strictly regulated by local changes in oxygen partial pressure (pO<sub>2</sub>) as under-deprived oxygen (hypoxia); the transcription factor hypoxia-inducible factor-2 induces EPO. However, erythropoiesis regulation extends beyond the well-established hypoxia-inducible factor (HIF)–EPO axis and involves processes modulated by other hypoxia pathway proteins (HPPs), including proteins involved in iron metabolism. The importance of a number of these factors is evident as their altered expression has been associated with various anemia-related disorders, including chronic kidney disease. Eventually, our emerging understanding of HPPs and their regulatory feedback will be instrumental in developing specific therapies for anemic patients and beyond.
first_indexed 2024-03-10T15:12:24Z
format Article
id doaj.art-d92d559385ff440fbc1f5f4fcd65b453
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T15:12:24Z
publishDate 2020-10-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-d92d559385ff440fbc1f5f4fcd65b4532023-11-20T19:14:20ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-10-012121813110.3390/ijms21218131Hypoxia Pathway Proteins are Master Regulators of ErythropoiesisDeepika Watts0Diana Gaete1Diego Rodriguez2David Hoogewijs3Martina Rauner4Sundary Sormendi5Ben Wielockx6Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, 01307 Dresden, GermanyInstitute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, 01307 Dresden, GermanyInstitute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, 01307 Dresden, GermanySection of Medicine, Department of Endocrinology, Metabolism and Cardiovascular System, University of Fribourg, 1700 Fribourg, SwitzerlandDepartment of Medicine III and Center for Healthy Aging, Technische Universität Dresden, 01307 Dresden, GermanyInstitute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, 01307 Dresden, GermanyInstitute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, 01307 Dresden, GermanyErythropoiesis is a complex process driving the production of red blood cells. During homeostasis, adult erythropoiesis takes place in the bone marrow and is tightly controlled by erythropoietin (EPO), a central hormone mainly produced in renal EPO-producing cells. The expression of EPO is strictly regulated by local changes in oxygen partial pressure (pO<sub>2</sub>) as under-deprived oxygen (hypoxia); the transcription factor hypoxia-inducible factor-2 induces EPO. However, erythropoiesis regulation extends beyond the well-established hypoxia-inducible factor (HIF)–EPO axis and involves processes modulated by other hypoxia pathway proteins (HPPs), including proteins involved in iron metabolism. The importance of a number of these factors is evident as their altered expression has been associated with various anemia-related disorders, including chronic kidney disease. Eventually, our emerging understanding of HPPs and their regulatory feedback will be instrumental in developing specific therapies for anemic patients and beyond.https://www.mdpi.com/1422-0067/21/21/8131hypoxiaerythropoiesisEPOHIFCKD
spellingShingle Deepika Watts
Diana Gaete
Diego Rodriguez
David Hoogewijs
Martina Rauner
Sundary Sormendi
Ben Wielockx
Hypoxia Pathway Proteins are Master Regulators of Erythropoiesis
International Journal of Molecular Sciences
hypoxia
erythropoiesis
EPO
HIF
CKD
title Hypoxia Pathway Proteins are Master Regulators of Erythropoiesis
title_full Hypoxia Pathway Proteins are Master Regulators of Erythropoiesis
title_fullStr Hypoxia Pathway Proteins are Master Regulators of Erythropoiesis
title_full_unstemmed Hypoxia Pathway Proteins are Master Regulators of Erythropoiesis
title_short Hypoxia Pathway Proteins are Master Regulators of Erythropoiesis
title_sort hypoxia pathway proteins are master regulators of erythropoiesis
topic hypoxia
erythropoiesis
EPO
HIF
CKD
url https://www.mdpi.com/1422-0067/21/21/8131
work_keys_str_mv AT deepikawatts hypoxiapathwayproteinsaremasterregulatorsoferythropoiesis
AT dianagaete hypoxiapathwayproteinsaremasterregulatorsoferythropoiesis
AT diegorodriguez hypoxiapathwayproteinsaremasterregulatorsoferythropoiesis
AT davidhoogewijs hypoxiapathwayproteinsaremasterregulatorsoferythropoiesis
AT martinarauner hypoxiapathwayproteinsaremasterregulatorsoferythropoiesis
AT sundarysormendi hypoxiapathwayproteinsaremasterregulatorsoferythropoiesis
AT benwielockx hypoxiapathwayproteinsaremasterregulatorsoferythropoiesis